Goldman SachsGSDON'T BUYMar 01, 2023Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
He used to work here 40 years ago. The bank has totally changed. GS is embracing everyday consumer banking; it paid $2.23 billion for Green Sky (which specializes in consumer loan originations) at the top of the fintech craze. He doesn't like this shift.; in his days he was pushed to bring in super-rich clients. Instead, GS should sell its consumer division entirely.